Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Pfizer's Lipitor revenue worldwide 2003-2018

Worldwide revenue of Pfizer's Lipitor from 2003 to 2018 (in million U.S. dollars)

by Matej Mikulic, last edited Aug 9, 2019
Pfizer's Lipitor revenue worldwide 2003-2018 During 2018, Pfizer’s Lipitor generated nearly 2.1 billion U.S. dollars of revenue. This was the second year in a row with a reported increase after the record-low in 2016, with revenues of 1.76 billion dollars. For around a decade cholesterol-lowering drug Lipitor was one of the company’s top blockbusters, with record-high revenues of approximately 13 billion U.S. dollars in 2006. In the year of patent loss – 2011 – Lipitor still generated roughly 10 billion dollars, before a heavy drop down to four billion dollars in 2012.
Pharmaceutical company Pfizer

Drug manufacturer Pfizer is headquartered in Midtown Manhattan, New York City. At this moment, it is the world’s leading pharmaceutical company based on pharmaceutical sales of prescribed and over-the-counter drugs. Today, the company is focused on human medicine, divided into two major segments - Innovative Health and Essential Health. However, until 2013 the company also had a notable animal health division which was spun-off and today is known as Zoetis.

Facts about Lipitor/atorvastatin

Lipitor was approved by the FDA (Food and Drug Administration) in 1996 for medical use. Since its patent protection expired in 2011, it is now also sold under its generic name atorvastatin. Today, atorvastatin is one of the most prescribed drugs in the United States. The drug is primarily used as prevention for people with a high risk for developing cardiovascular diseases and as a treatment for abnormal lipid levels (dyslipidemia). Generic versions of Lipitor lead to annual savings in drug spending of around 16 billion U.S. dollars.
Show more

Worldwide revenue of Pfizer's Lipitor from 2003 to 2018 (in million U.S. dollars)

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Pfizer
Pfizer

All Information
in one Presentation

Pfizer

Everything On "Pfizer" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Pfizer"
  • Global positioning
  • Revenues
  • Selected top products
The most important statistics
  • Expenditures/payments
  • Other key data
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.